Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

18 June 2025

Glenmark Pharmaceuticals receives five observations from USFDA following Monroe facility inspection

Glenmark Pharmaceuticals Ltd. has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practices (GMP) inspection at its manufacturing facility in Monroe, North Carolina, USA.
16 June 2025

Dupilumab demonstrated superiority over Omalizumab in Chronic Rhinosinusitis with Nasal Polyps

Regeneron Pharmaceuticals, Inc. and Sanofi presented positive results from the EVEREST Phase 4 trial in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma. In the trial, Dupixent.
16 June 2025

Roche to advance prasinezumab into Phase III development for early-stage Parkinson's disease

Roche announced today its decision to proceed with Phase III development of prasinezumab, an investigational anti-alpha-synuclein antibody, in early-stage Parkinson’s disease.
16 June 2025

Bristol Myers Squibb expands radiopharmaceutical pipeline through RayzeBio–Philochem Partnership

The agreement grants RayzeBio exclusive worldwide rights to Philochem’s clinical-stage radiopharmaceutical candidate OncoACP3.
14 June 2025

Amneal receives USFDA Approval for Prednisolone Acetate Ophthalmic Suspension

Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte.
13 June 2025

Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial

Apex Labs Ltd. a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the approval by the Israeli MoH and IRBs to open two additional clinical trial sites for SUMMIT-90.
13 June 2025

ORLADEYO® (berotralstat) approved in Colombia

BioCryst Pharmaceuticals, Inc. announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO
13 June 2025

Newly discovered cancer cell energy pathway blocked with natural substance

Looking to nature for answers to complex questions can reveal new and unprecedented results that can even affect cells on molecular levels.
13 June 2025

Sea Cucumbers Could Hold Key to Stopping Cancer Spread

Sea cucumbers are the ocean's janitors, cleaning the seabed and recycling nutrients back into the water. But this humble marine invertebrate could also hold the key to stopping the spread of cancer.
12 June 2025

Bharat Biotech to advance GSKs Shigella vaccine candidate

Bharat Biotech International Limited (BBIL) has entered into a licensing agreement with GSK plc to take over the development of altSonflex1‑2‑3, GSK’s promising Shigella vaccine candidate.